Jinfeng Liu

ORCID: 0000-0001-8349-8593 · 2 papers in corpus
review 2023
·doi:10.37766/inplasy2023.9.0029

eview question / Objective The aim of this study is to comprehensively analyze evidence of elagolix in the treatment of moderateto-severe endometriosis-associated pain.Condition being studied Endometriosis-related pain, such as dysmenorrhea…

2022
·doi:10.21203/rs.3.rs-1256751/v1

The aim of this study is to design a novel pH and photothermal dual-responsive nanodrug delivery system with high biocompatibility and tumor targeting. Based on the high loading rate and good photothermal properties of graphene oxide (GO), …